A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.

A number of neoplasms are known to express somatostatin receptors, and the use of somatostatin receptor imaging in their localization has recently been described. We compared an 123I-labeled somatostatin analog Tyr-3-octreotide (TOCT) and 123I-labeled metaiodobenzylguanidine (MIBG) scintigraphy in s...

Description complète

Détails bibliographiques
Auteurs principaux: Bomanji, J, Mather, S, Moyes, J, Ellison, D, Grossman, A, Britton, K, Besser, G
Format: Journal article
Langue:English
Publié: 1992

Documents similaires